跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,864 条关于
“TYK2 inhibitors”
全部
13,864
临床试验
6,395
药物
3,232
机构
10
资讯
4,227
去年
Novel Oral Psoriasis Therapies Show Promise: TYK2 Inhibitors Lead Breakthrough Advances
去年
Sareum Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Penetrating TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases
去年
Zasocitinib: AI-Designed TYK2 Inhibitor Shows Promise in Psoriasis and Psoriatic Arthritis Treatment
10个月前
Sudo Biosciences Reports Positive Phase 1 Results for Brain-Penetrant TYK2 Inhibitor SUDO-550 in Neuroinflammatory Diseases
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
9个月前
Lynk Pharmaceuticals Receives FDA IND Approval for Brain-Penetrant TYK2 Inhibitor LNK01006 Targeting Neuroinflammatory Diseases
去年
Sudo Biosciences Initiates Phase I Trial of Brain-Penetrant TYK2 Inhibitor SUDO-550 for Neuroinflammation
去年
InventisBio's D-2570 Shows Promise in Phase 2 Psoriasis Trial
去年
JAK Inhibitors Show Promising Long-term Safety and Efficacy in Atopic Dermatitis Treatment, Yale Expert Reports
第 1 页,共 423 页
上一页
下一页